Skip to main content
. 2016 Jun 12;5(8):1856–1862. doi: 10.1002/cam4.777

Figure 1.

Figure 1

Expression of miR‐133b in 146 urothelial carcinoma of the bladder (UCB) specimens and matched adjacent non‐neoplastic bladder tissues were measured by quantitative real‐time polymerase chain reaction. (A) The expression of miR‐133b in UCB tissues and adjacent non‐neoplastic bladder tissues. (B) The expression level of miR‐133b in muscle invasive bladder cancer (≥T2) and nonmuscle invasive bladder cancer (Ta–T1). (C) The expression level of miR‐133b in UCB tissues with papillary urothelial neoplasm of low malignant potential (PUNLMP), low (LG) and high (HG) pathological grades, respectively. *indicates P < 0 .01.